ReShape Lifesciences Quote - RSLS

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

5.15

Bid

4.84

Offer

5.11

Volume

600

4.93 Day's Range 5.15

4.09 52 Week Range 29.00

Market Cap

3.67M

Previous Close

5.00

Open

4.94

Last Trade

5.14

Last Trade Time

01:30:14

Financial Volume

US$ 3,002

VWAP

5.0028

Average Volume (3m)

75,486

Shares Outstanding

712,680

Dividend Yield

PE Ratio

-0.32

Earnings Per Share (EPS)

-15.98

Revenue

8.68M

Net Profit

-11.39M

Reshape Lifesciences Inc is a developer of minimally invasive medical devices to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, the ReShape Vest, an investigational device, to help treat more patients with obesity, a... Reshape Lifesciences Inc is a developer of minimally invasive medical devices to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, the ReShape Vest, an investigational device, to help treat more patients with obesity, and ReShapeCare, a virtual coaching program delivered through an app. Show more

Sector

Surgical,med Instr,apparatus

Industry

Surgical,med Instr,apparatus

Website

www.reshapelifesciences.com

Headquarters

Wilmington, Delaware, USA

Founded

ReShape Lifesciences Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker RSLS. The last closing price for ReShape Lifesciences was US$5. Over the last year, ReShape Lifesciences shares have traded in a share price range of US$ 4.09 to US$ 29.00.

ReShape Lifesciences currently has 712,680 shares in issue. The market capitalisation of ReShape Lifesciences is US$3.56 million. ReShape Lifesciences has a price to earnings ratio (PE ratio) of -0.32.

ReShape Lifesciences® Provides Update on Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement With Biorad Medisys

IRVINE, Calif. and CAMBRIDGE, Mass., Jan. 13, 2025 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, and...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.19	3.83064516129	4.96	5.19	4.35	36720	4.89458796	CS
4	0.63	13.9380530973	4.52	5.19	4.09	22768	4.68501758	CS
12	-1.23	-19.2789968652	6.38	6.9033	4.09	75486	5.53215679	CS
26	-7.3606	-58.834907998	12.5106	13.9142	4.09	332353	8.79160049	CS
52	-9.814	-65.5840684309	14.964	29	4.09	1891530	13.63707487	CS
156	-4228.85	-99.8783656117	4234	4582	4.09	1520799	143.31231728	CS
260	-747.98	-99.3161871125	753.13	27550	4.09	1412270	3158.88539796	CS

RSLS - Frequently Asked Questions (FAQ)

What is the current ReShape Lifesciences share price?

The current share price of ReShape Lifesciences is US$ 5.15

How many ReShape Lifesciences shares are in issue?

ReShape Lifesciences has 712,680 shares in issue

What is the market cap of ReShape Lifesciences?

The market capitalisation of ReShape Lifesciences is USD 3.56M

What is the 1 year trading range for ReShape Lifesciences share price?

ReShape Lifesciences has traded in the range of US$ 4.09 to US$ 29.00 during the past year

What is the PE ratio of ReShape Lifesciences?

The price to earnings ratio of ReShape Lifesciences is -0.32

What is the cash to sales ratio of ReShape Lifesciences?

The cash to sales ratio of ReShape Lifesciences is 0.42

What is the reporting currency for ReShape Lifesciences?

ReShape Lifesciences reports financial results in USD

What is the latest annual turnover for ReShape Lifesciences?

The latest annual turnover of ReShape Lifesciences is USD 8.68M

What is the latest annual profit for ReShape Lifesciences?

The latest annual profit of ReShape Lifesciences is USD -11.39M

What is the registered address of ReShape Lifesciences?

The registered address for ReShape Lifesciences is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the ReShape Lifesciences website address?

The website address for ReShape Lifesciences is www.reshapelifesciences.com

Which industry sector does ReShape Lifesciences operate in?

ReShape Lifesciences operates in the SURGICAL,MED INSTR,APPARATUS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AALAmerican Airlines Group Inc	US$ 17.60 (0.00%)	339.33k
AAGRAfrican Agriculture Holdings Inc	US$ 0.1326 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	US$ 69.41 (0.00%)	0
AADIAadi Bioscience Inc	US$ 3.02 (0.00%)	1.58k
AACGATA Creativity Global	US$ 0.94 (0.00%)	2
AALAmerican Airlines Group Inc	US$ 17.60 (0.00%)	339.33k
AAGRAfrican Agriculture Holdings Inc	US$ 0.1326 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	US$ 69.41 (0.00%)	0
AADIAadi Bioscience Inc	US$ 3.02 (0.00%)	1.58k
AACGATA Creativity Global	US$ 0.94 (0.00%)	2
NMHINatures Miracle Holding Inc	US$ 1.13 (0.00%)	52.99M
PIIIP3 Partners Inc	US$ 0.2149 (0.00%)	52.72M
ERNAEterna Therapeutics Inc	US$ 0.309 (0.00%)	48.85M
AIFFFirefly Neuroscience Inc	US$ 1.90 (0.00%)	41.56M
LAESSEALSQ Corporation	US$ 3.35 (0.00%)	29.65M